ISOLATION OF TUMOR-DERIVED IMMUNOGLOBULIN-IDIOTYPE FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN A B-CELL LYMPHOMA PATIENT WITH MINIMAL DISEASE

Citation
L. Alvarezvallina et al., ISOLATION OF TUMOR-DERIVED IMMUNOGLOBULIN-IDIOTYPE FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN A B-CELL LYMPHOMA PATIENT WITH MINIMAL DISEASE, Journal of immunotherapy with emphasis on tumor immunology, 17(3), 1995, pp. 194-198
Citations number
15
Categorie Soggetti
Immunology,Oncology,"Medicine, Research & Experimental
ISSN journal
10675582
Volume
17
Issue
3
Year of publication
1995
Pages
194 - 198
Database
ISI
SICI code
1067-5582(1995)17:3<194:IOTIFP>2.0.ZU;2-G
Abstract
Active immunization with autologous idiotypic immunoglobulin, obtained by somatic fusion techniques, has been shown to be a useful alternati ve treatment in patients with B-cell lymphoma. Nevertheless, the requi rement for biopsy specimens to obtain lymphoma cells could be a limita tion to this therapeutic strategy. We address the question of whether peripheral blood samples containing small amounts of tumor cells can b e used as appropriate fusion partners to rescue tumor-derived idiotypi c proteins. In this report, we show that hybrid cells can be obtained from somatic fusions of K6H6/B5 heterohybridoma with lymphoma cells ob tained from both lymph node (LN) and peripheral blood mononuclear cell s (PBMC) containing only minor amounts of tumor cells. Some hybrid cel ls obtained from LN or PBMC fusions present an immunoglobulin (Ig) hea vy-chain gene rearrangement identical with that of the original tumor and secrete identical Ig protein containing the expected H and L chain s.